{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T10:51:47Z","timestamp":1785581507434,"version":"3.56.0"},"reference-count":85,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001843","name":"Science and Engineering Research Board","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001843","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001409","name":"India Ministry of Science & Technology Department of Science and Technology","doi-asserted-by":"publisher","award":["CRG\/2019\/000267"],"award-info":[{"award-number":["CRG\/2019\/000267"]}],"id":[{"id":"10.13039\/501100001409","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic Chemistry"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.bioorg.2026.109647","type":"journal-article","created":{"date-parts":[[2026,2,16]],"date-time":"2026-02-16T16:11:32Z","timestamp":1771258292000},"page":"109647","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Repurposing amide-based drugs unveils inhibition mechanisms of plasmodium falciparum Plasmepsin V enzymatic activity for antimalarial therapy"],"prefix":"10.1016","volume":"173","author":[{"given":"Anitadevi K.","family":"Prajapati","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Garima","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manu","family":"Lopus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sinjan","family":"Choudhary","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.bioorg.2026.109647_bb0005","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1590\/0074-02760140466","article-title":"Study of the antimalarial properties of hydroxyethylamine derivatives using green fluorescent protein transformed plasmodium berghei","volume":"110","author":"Souza","year":"2015","journal-title":"Mem. Inst. Oswaldo Cruz"},{"issue":"1","key":"10.1016\/j.bioorg.2026.109647_bb0010","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1021\/acsmedchemlett.9b00457","article-title":"Dialkyldioxonaphthoimidazoliums: synthesis, biological activity, and structure-activity relationships","volume":"11","author":"Ahenkorah","year":"2019","journal-title":"ACS Med. Chem. Lett."},{"issue":"9","key":"10.1016\/j.bioorg.2026.109647_bb0015","first-page":"223","article-title":"Antimalarial mechanisms and resistance status of artemisinin and its derivatives","volume":"9","author":"Zheng","year":"2024","journal-title":"Trop Med. Infect. Dis."},{"key":"10.1016\/j.bioorg.2026.109647_bb0020","first-page":"275","article-title":"Hemoglobin degradation","volume":"295","author":"Goldberg","year":"2005","journal-title":"Curr. Top. Microbiol. Immunol."},{"key":"10.1016\/j.bioorg.2026.109647_bb0025","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1016\/j.ijpara.2004.10.003","article-title":"Cysteine proteases of malaria parasites","volume":"34","author":"Rosenthal","year":"2004","journal-title":"Int. J. Parasitol."},{"issue":"3","key":"10.1016\/j.bioorg.2026.109647_bb0030","doi-asserted-by":"crossref","first-page":"182","DOI":"10.3390\/pathogens13030182","article-title":"The digestive vacuole of the malaria parasite: a specialized lysosome","volume":"13","author":"Wiser","year":"2024","journal-title":"Pathogens"},{"issue":"7","key":"10.1016\/j.bioorg.2026.109647_bb0035","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1016\/j.pt.2022.02.010","article-title":"Plasmodium's bottomless pit: properties and functions of the malaria parasite's digestive vacuole","volume":"38","author":"Matz","year":"2022","journal-title":"Trends Parasitol."},{"issue":"30","key":"10.1016\/j.bioorg.2026.109647_bb0040","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2306420120","article-title":"The role of plasmodium V-ATPase in vacuolar physiology and antimalarial drug uptake","volume":"120","author":"Alder","year":"2023","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.bioorg.2026.109647_bb0045","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1016\/j.mib.2006.06.006","article-title":"Evidence for the importance of genetic structuring to the structural and functional specialization of the plasmodium falciparum var gene family","volume":"9","author":"Kraemer","year":"2006","journal-title":"Curr. Opin. Microbiol."},{"issue":"5","key":"10.1016\/j.bioorg.2026.109647_bb0050","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1111\/tra.12053","article-title":"Role of plasmepsin V in export of diverse protein families from the plasmodium falciparum exportome","volume":"14","author":"Boddey","year":"2013","journal-title":"Traffic"},{"key":"10.1016\/j.bioorg.2026.109647_bb0055","doi-asserted-by":"crossref","first-page":"31420","DOI":"10.1038\/srep31420","article-title":"Understanding the structural basis of substrate recognition by plasmodium falciparum plasmepsin V to aid in the design of potent inhibitors","volume":"6","author":"Bedi","year":"2016","journal-title":"Sci. Rep."},{"issue":"7281","key":"10.1016\/j.bioorg.2026.109647_bb0060","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1038\/nature08728","article-title":"An aspartyl protease directs malaria effector proteins to the host cell","volume":"463","author":"Boddey","year":"2010","journal-title":"Nature"},{"issue":"3","key":"10.1016\/j.bioorg.2026.109647_bb0065","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1111\/j.1600-0854.2008.00864.x","article-title":"Role of the plasmodium export element in trafficking parasite proteins to the infected erythrocyte","volume":"10","author":"Boddey","year":"2009","journal-title":"Traffic"},{"issue":"12","key":"10.1016\/j.bioorg.2026.109647_bb0070","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0207621","article-title":"Essentiality of plasmodium falciparum plasmepsin V","volume":"13","author":"Boonyalai","year":"2018","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.bioorg.2026.109647_bb0075","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.molbiopara.2008.04.011","article-title":"N-terminal processing of proteins exported by malaria parasites","volume":"160","author":"Chang","year":"2008","journal-title":"Mol. Biochem. Parasitol."},{"key":"10.1016\/j.bioorg.2026.109647_bb0080","series-title":"Natural Remedies in the Fight against Parasites","first-page":"183","article-title":"Plasmepsin: Function, characterization and targeted antimalarial drug development","author":"Liu","year":"2017"},{"issue":"12","key":"10.1016\/j.bioorg.2026.109647_bb0085","doi-asserted-by":"crossref","first-page":"3796","DOI":"10.1016\/j.celrep.2019.11.073","article-title":"Inhibition of plasmepsin V activity blocks plasmodium falciparum gametocytogenesis and transmission to mosquitoes","volume":"29","author":"Jennison","year":"2019","journal-title":"Cell Rep."},{"issue":"2","key":"10.1016\/j.bioorg.2026.109647_bb0090","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1021\/acsptsci.0c00222","article-title":"Repurposing quinoline and artemisinin antimalarials as therapeutics for SARS-CoV-2: rationale and implications","volume":"4","author":"Firestone","year":"2021","journal-title":"ACS Pharmacol. Transl. Sci."},{"key":"10.1016\/j.bioorg.2026.109647_bb0095","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1186\/s12936-024-04967-2","article-title":"Repurposing of antimalarial drugs for the treatment of tuberculosis: realistic strategy or fanciful dead end?","volume":"23","author":"Hanscheid","year":"2024","journal-title":"Malar. J."},{"key":"10.1016\/j.bioorg.2026.109647_bb0100","doi-asserted-by":"crossref","first-page":"4431","DOI":"10.1021\/cr010167q","article-title":"Structure and mechanism of the pepsin-like family of aspartic proteases","volume":"102","author":"Dunn","year":"2002","journal-title":"Chem. Rev."},{"issue":"11","key":"10.1016\/j.bioorg.2026.109647_bb0105","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1016\/S1471-4922(01)02037-2","article-title":"Aspartic proteases of plasmodium falciparum and other parasitic protozoa as drug targets","volume":"17","author":"Coombs","year":"2001","journal-title":"Trends Parasitol."},{"issue":"9","key":"10.1016\/j.bioorg.2026.109647_bb0110","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1016\/0968-0896(96)00147-2","article-title":"A new class of HIV-1 protease inhibitor: the crystallographic structure, inhibition and chemical synthesis of an aminimide peptide isostere","volume":"4","author":"Rutenber","year":"1996","journal-title":"Bioorg. Med. Chem."},{"issue":"9","key":"10.1016\/j.bioorg.2026.109647_bb0115","doi-asserted-by":"crossref","first-page":"1993","DOI":"10.1016\/j.bmc.2016.03.027","article-title":"Exploration of the P3 region of PEXEL peptidomimetics leads to a potent inhibitor of the plasmodium protease, plasmepsin V","volume":"24","author":"Gazdik","year":"2016","journal-title":"Bioorg. Med. Chem."},{"issue":"12","key":"10.1016\/j.bioorg.2026.109647_bb0120","doi-asserted-by":"crossref","first-page":"3259","DOI":"10.1002\/anie.201309682","article-title":"Structure-based design of inhibitors of the aspartic protease endothiapepsin by exploiting dynamic combinatorial chemistry","volume":"53","author":"Mondal","year":"2014","journal-title":"Angew. Chem. Int. Ed. Eng."},{"key":"10.1016\/j.bioorg.2026.109647_bb0125","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2021.111275","article-title":"Repurposing of existing therapeutics to combat drug resistant malaria","volume":"136","author":"Yadav","year":"2021","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.bioorg.2026.109647_bb0130","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.drudis.2018.08.006","article-title":"New leads for drug repurposing against malaria","volume":"24","author":"Pazhayam","year":"2019","journal-title":"Drug Discov. Today"},{"issue":"2","key":"10.1016\/j.bioorg.2026.109647_bb0135","doi-asserted-by":"crossref","first-page":"273","DOI":"10.3390\/jcm10020273","article-title":"Favipiravir in therapy of viral infections","volume":"10","author":"\u0141agocka","year":"2021","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.bioorg.2026.109647_bb0140","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.antiviral.2018.03.003","article-title":"Favipiravir as a potential countermeasure against neglected and emerging RNA viruses","volume":"153","author":"Delang","year":"2018","journal-title":"Antivir. Res."},{"issue":"5","key":"10.1016\/j.bioorg.2026.109647_bb0145","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1038\/nrc1074","article-title":"5-fluorouracil: mechanisms of action and clinical strategies","volume":"3","author":"Longley","year":"2003","journal-title":"Nat. Rev. Cancer"},{"issue":"1","key":"10.1016\/j.bioorg.2026.109647_bb0150","doi-asserted-by":"crossref","first-page":"93","DOI":"10.2165\/00003495-199652010-00007","article-title":"Saquinavir: a review of its pharmacology and clinical potential in the management of HIV infection","volume":"52","author":"Noble","year":"1996","journal-title":"Drugs"},{"key":"10.1016\/j.bioorg.2026.109647_bb0155","first-page":"1","article-title":"Saquinavir (Invirase): first protease inhibitor approved \u2014 reimbursement, information hotline numbers","volume":"237","author":"James","year":"1995","journal-title":"AIDS Treat. News"},{"issue":"3","key":"10.1016\/j.bioorg.2026.109647_bb0160","doi-asserted-by":"crossref","first-page":"189","DOI":"10.2165\/00003088-199834030-00002","article-title":"Saquinavir: clinical pharmacology and efficacy","volume":"34","author":"Vella","year":"1998","journal-title":"Clin. Pharmacokinet."},{"issue":"6","key":"10.1016\/j.bioorg.2026.109647_bb0165","doi-asserted-by":"crossref","first-page":"1542","DOI":"10.1007\/s43440-020-00175-2","article-title":"Favipiravir use for SARS CoV-2 infection","volume":"72","author":"Boretti","year":"2020","journal-title":"Pharmacol. Rep."},{"issue":"6","key":"10.1016\/j.bioorg.2026.109647_bb0170","doi-asserted-by":"crossref","first-page":"2207","DOI":"10.1128\/AAC.00022-06","article-title":"Antimalarial effects of human immunodeficiency virus type 1 protease inhibitors differ from those of the aspartic protease inhibitor pepstatin","volume":"50","author":"Parikh","year":"2006","journal-title":"Antimicrob. Agents Chemother."},{"issue":"1","key":"10.1016\/j.bioorg.2026.109647_bb0175","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.molbiopara.2015.05.004","article-title":"Plasmodium falciparum plasmepsin V (PfPMV): insights into recombinant expression, substrate specificity and active site structure","volume":"201","author":"Boonyalai","year":"2015","journal-title":"Mol. Biochem. Parasitol."},{"key":"10.1016\/j.bioorg.2026.109647_bb0180","doi-asserted-by":"crossref","DOI":"10.1016\/j.molliq.2024.124158","article-title":"Inhibiting the activity of malarial drug target plasmepsin V by quinolines in aqueous medium","volume":"397","author":"Prajapati","year":"2024","journal-title":"J. Mol. Liq."},{"key":"10.1016\/j.bioorg.2026.109647_bb0185","first-page":"92607","article-title":"Spectroscopic and molecular docking studies on binding interactions of camptothecin drugs with bovine serum albumin","volume":"15","author":"Wang","year":"2025","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bioorg.2026.109647_bb0190","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/s13065-023-00944-z","article-title":"Insights on the in-vitro binding interaction between donepezil and bovine serum albumin: thermodynamic and spectroscopic analysis","volume":"17","author":"El Gammal","year":"2023","journal-title":"BMC Chem."},{"issue":"47","key":"10.1016\/j.bioorg.2026.109647_bb0195","doi-asserted-by":"crossref","first-page":"24147","DOI":"10.1021\/jp062734p","article-title":"Binding of naproxen and amitriptyline to bovine serum albumin: biophysical aspects","volume":"110","author":"Banerjee","year":"2006","journal-title":"J. Phys. Chem. B"},{"key":"10.1016\/j.bioorg.2026.109647_bb0200","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.biochi.2025.12.006","article-title":"Inhibiting catalytic activity of plasmodium falciparum aspartate protease plasmepsin V: a biochemical approach to malaria intervention","volume":"242","author":"Prajapati","year":"2025","journal-title":"Biochimie"},{"issue":"1","key":"10.1016\/j.bioorg.2026.109647_bb0205","doi-asserted-by":"crossref","first-page":"2245168","DOI":"10.1080\/14756366.2023.2245168","article-title":"Mixed and non-competitive enzyme inhibition: underlying mechanisms and mechanistic irrelevance of the formal two-site model","volume":"38","author":"Pesaresi","year":"2023","journal-title":"J. Enzyme Inhib. Med. Chem."},{"issue":"23","key":"10.1016\/j.bioorg.2026.109647_bb0210","doi-asserted-by":"crossref","first-page":"3099","DOI":"10.1016\/0006-2952(73)90196-2","article-title":"Relationship between the inhibition constant (Ki) and the concentration of inhibitor which causes 50 per cent inhibition (IC50) of an enzymatic reaction","volume":"22","author":"Cheng","year":"1973","journal-title":"Biochem. Pharmacol."},{"issue":"W1","key":"10.1016\/j.bioorg.2026.109647_bb0215","doi-asserted-by":"crossref","first-page":"W159","DOI":"10.1093\/nar\/gkac394","article-title":"CB-dock2: improved protein-ligand blind docking by integrating cavity detection, docking and homologous template fitting","volume":"50","author":"Liu","year":"2022","journal-title":"Nucleic Acids Res."},{"issue":"7873","key":"10.1016\/j.bioorg.2026.109647_bb0220","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1038\/s41586-021-03819-2","article-title":"Highly accurate protein structure prediction with AlphaFold","volume":"596","author":"Jumper","year":"2021","journal-title":"Nature"},{"issue":"D1","key":"10.1016\/j.bioorg.2026.109647_bb0225","doi-asserted-by":"crossref","first-page":"D1388","DOI":"10.1093\/nar\/gkaa971","article-title":"PubChem, new data content and improved web interfaces","volume":"49","author":"Kim","year":"2021","journal-title":"Nucleic Acids Res."},{"issue":"14","key":"10.1016\/j.bioorg.2026.109647_bb0230","doi-asserted-by":"crossref","first-page":"4568","DOI":"10.3390\/molecules27144568","article-title":"Protein-ligand docking in the machine-learning era","volume":"27","author":"Yang","year":"2022","journal-title":"Molecules"},{"key":"10.1016\/j.bioorg.2026.109647_bb0235","doi-asserted-by":"crossref","first-page":"bbac032","DOI":"10.1093\/bib\/bbac087","article-title":"FitDock: protein\u2013ligand docking by template fitting","volume":"23","author":"Yang","year":"2022","journal-title":"Brief. Bioinform."},{"key":"10.1016\/j.bioorg.2026.109647_bb0240","first-page":"1217","article-title":"CB-dock: a web server for cavity detection-guided protein\u2013ligand blind docking","volume":"40","author":"Liu","year":"2019","journal-title":"Acta Pharmacol. Sin."},{"issue":"10","key":"10.1016\/j.bioorg.2026.109647_bb0245","doi-asserted-by":"crossref","first-page":"2778","DOI":"10.1021\/ci200227u","article-title":"LigPlot+: multiple ligand-protein interaction diagrams for drug discovery","volume":"51","author":"Laskowski","year":"2011","journal-title":"J. Chem. Inf. Model."},{"key":"10.1016\/j.bioorg.2026.109647_bb0250","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pbio.1001897","article-title":"Inhibition of plasmepsin V activity demonstrates its essential role in protein export, PfEMP1 display, and survival of malaria parasites","volume":"12","author":"Sleebs","year":"2014","journal-title":"PLoS Biol."},{"issue":"W1","key":"10.1016\/j.bioorg.2026.109647_bb0255","doi-asserted-by":"crossref","first-page":"W521","DOI":"10.1093\/nar\/gkae241","article-title":"The EMBL-EBI job dispatcher sequence analysis tools framework in 2024","volume":"52","author":"Madeira","year":"2024","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.bioorg.2026.109647_bb0260","first-page":"1","article-title":"Evaluation of enzyme inhibitors in drug discovery. A guide for medicinal chemists and pharmacologists","volume":"46","author":"Copeland","year":"2005","journal-title":"Methods Biochem. Anal."},{"issue":"23","key":"10.1016\/j.bioorg.2026.109647_bb0265","doi-asserted-by":"crossref","first-page":"7203","DOI":"10.1021\/acs.langmuir.1c00773","article-title":"Correlating the properties of antibiotics with the energetics of partitioning in colloidal self-assemblies and the effect on the binding of a released drug with a target protein","volume":"37","author":"Judy","year":"2021","journal-title":"Langmuir"},{"key":"10.1016\/j.bioorg.2026.109647_bb0270","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/j.jct.2016.08.020","article-title":"Binding thermodynamics of diclofenac and naproxen with human and bovine serum albumins: a calorimetric and spectroscopic study, the","volume":"103","author":"Fadi","year":"2016","journal-title":"J. Chem. Thermodyn."},{"key":"10.1016\/j.bioorg.2026.109647_bb0275","doi-asserted-by":"crossref","first-page":"11767","DOI":"10.1021\/bi00205a012","article-title":"Stability of myoglobin: a model for the folding of heme proteins","volume":"33","author":"Hargrove","year":"1994","journal-title":"Biochemistry"},{"key":"10.1016\/j.bioorg.2026.109647_bb0280","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1016\/j.molliq.2018.07.017","article-title":"Elucidation of energetics and mode of recognition of green tea polyphenols by human serum albumin","volume":"265","author":"Save","year":"2018","journal-title":"J. Mol. Liq."},{"issue":"1","key":"10.1016\/j.bioorg.2026.109647_bb0285","doi-asserted-by":"crossref","DOI":"10.1002\/jmr.3112","article-title":"Deciphering Saquinavir-bovine serum albumin interactions: spectroscopic and computational insights","volume":"38","author":"Rajendran","year":"2025","journal-title":"J. Mol. Recognit."},{"key":"10.1016\/j.bioorg.2026.109647_bb0290","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.jphotobiol.2011.11.004","article-title":"Interaction of 5-fluorouracil and its derivatives with bovine serum albumin","volume":"107","author":"Abdi","year":"2012","journal-title":"J. Photochem. Photobiol. B"},{"issue":"9","key":"10.1016\/j.bioorg.2026.109647_bb0295","doi-asserted-by":"crossref","first-page":"102355","DOI":"10.1016\/j.jbc.2022.102355","article-title":"The nepenthesin insert in the Plasmodium falciparum aspartic protease plasmepsin V is necessary for enzyme function","volume":"298","author":"Polino","year":"2022","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bioorg.2026.109647_bb0300","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1039\/C4MB00631C","article-title":"Molecular insight into proposed parameters and molecular dynamics","volume":"11","author":"Karubiu","year":"2015","journal-title":"Mol. BioSyst."},{"issue":"6","key":"10.1016\/j.bioorg.2026.109647_bb0305","doi-asserted-by":"crossref","DOI":"10.1002\/pro.4651","article-title":"Substrate binding in the allosteric site mimics homotropic cooperativity in the SIS-fold glucosamine-6-phosphate deaminases","volume":"32","author":"Marcos-Viquez","year":"2023","journal-title":"Protein Sci."},{"issue":"12","key":"10.1016\/j.bioorg.2026.109647_bb0310","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.3390\/catal15121139","article-title":"Bridging disciplines in enzyme kinetics: understanding steady-state, transient-state and performance parameters","volume":"15","author":"Ma","year":"2025","journal-title":"Catalysts"},{"key":"10.1016\/j.bioorg.2026.109647_bb0315","article-title":"Tumor-targeted liposomes with platycodin D2 promote apoptosis in colorectal cancer","volume":"22","author":"Cho","year":"2023","journal-title":"Mater. Today Bio"},{"issue":"12","key":"10.1016\/j.bioorg.2026.109647_bb0320","doi-asserted-by":"crossref","first-page":"7708","DOI":"10.1007\/s12010-023-04490-1","article-title":"Homology modeling, screening, and identification of potential FOXO6 inhibitors curtail gastric cancer progression: an in-silico drug repurposing approach","volume":"195","author":"Poleboyina","year":"2023","journal-title":"Appl. Biochem. Biotechnol."},{"key":"10.1016\/j.bioorg.2026.109647_bb0325","first-page":"1","article-title":"Investigations on the interactions of 5-fluorouracil with bovine serum albumin: optical spectroscopic and molecular modelling studies","volume":"151","author":"Chinnathambi","year":"2014","journal-title":"JOL"},{"issue":"2","key":"10.1016\/j.bioorg.2026.109647_bb0330","doi-asserted-by":"crossref","first-page":"2023020","DOI":"10.31893\/multiscience.2023020","article-title":"Development and validation of ultraviolet spectrophotometric method for Saquinavir estimation in bulk and dosage form","volume":"5","author":"Mujawar","year":"2023","journal-title":"Multidiscip. Sci. J."},{"issue":"7","key":"10.1016\/j.bioorg.2026.109647_bb0335","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.1093\/jac\/dkaf129","article-title":"Plasmodium falciparum isolates: ex vivo drug response","volume":"80","author":"Adika","year":"2025","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.bioorg.2026.109647_bb0340","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1186\/1475-2875-13-207","article-title":"Ex vivo anti-malarial drugs sensitivity profile of plasmodium falciparum field isolates from Burkina Faso five years after the national policy change","volume":"13","author":"Tinto","year":"2014","journal-title":"Malar. J."},{"issue":"2","key":"10.1016\/j.bioorg.2026.109647_bb0345","doi-asserted-by":"crossref","first-page":"193","DOI":"10.4269\/ajtmh.1994.50.193","article-title":"In vitro activity of pyrimethamine, cycloguanil, and other antimalarial drugs against African isolates and clones of plasmodium falciparum","volume":"50","author":"Basco","year":"1994","journal-title":"Am. J. Trop. Med. Hyg."},{"issue":"4","key":"10.1016\/j.bioorg.2026.109647_bb0350","doi-asserted-by":"crossref","first-page":"388","DOI":"10.4269\/ajtmh.1995.53.388","article-title":"In vitro activity of atovaquone against the African isolates and clones of plasmodium falciparum","volume":"53","author":"Basco","year":"1995","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"10.1016\/j.bioorg.2026.109647_bb0355","series-title":"OECD Series on Testing and Assessment","article-title":"Guidance document on using cytotoxicity tests to estimate starting doses for acute Oral systematic toxicity tests","volume":"129","author":"OECD","year":"2010"},{"key":"10.1016\/j.bioorg.2026.109647_bb0360","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1186\/1475-2875-12-408","article-title":"Identification of inhibitors of plasmodium falciparum gametocyte development","volume":"12","author":"Duffy","year":"2013","journal-title":"Malar. J."},{"issue":"6","key":"10.1016\/j.bioorg.2026.109647_bb0365","doi-asserted-by":"crossref","first-page":"1658","DOI":"10.1128\/AAC.46.6.1658-1664.2002","article-title":"Histidine-rich protein II: a novel approach to malaria drug sensitivity testing","volume":"46","author":"Noedl","year":"2002","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.bioorg.2026.109647_bb0370","article-title":"In silico identification and inhibition of regulatory protein involved in E. Coli-induced bovine mastitis","volume":"19","author":"Sivaramakrishnan","year":"2020","journal-title":"Inform. Med. Unlocked."},{"key":"10.1016\/j.bioorg.2026.109647_bb0375","doi-asserted-by":"crossref","first-page":"1674","DOI":"10.1093\/bioinformatics\/btu104","article-title":"Improved protein-ligand binding affinity prediction by using a curvature-dependent surface-area model","volume":"30","author":"Cao","year":"2014","journal-title":"Bioinformatics"},{"key":"10.1016\/j.bioorg.2026.109647_bb0380","doi-asserted-by":"crossref","DOI":"10.1177\/11779322241240651","article-title":"Computer-assisted discovery of Salvia fruticosa compounds with schistosomicidal activity","volume":"18","author":"Shoko","year":"2024","journal-title":"Bioinformatics Biol. Insights"},{"issue":"12","key":"10.1016\/j.bioorg.2026.109647_bb0385","first-page":"1013","article-title":"Malaria parasite plasmepsin V inhibitors: opportunities and challenges for antimalarial drug development","volume":"25","author":"Ansell","year":"2021","journal-title":"Expert Opin. Ther. Targets"},{"key":"10.1016\/j.bioorg.2026.109647_bb0390","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.biochi.2018.07.002","article-title":"In vitro and in silico studies of naphthoquinones and peptidomimetics toward plasmodium falciparum plasmepsin V","volume":"152","author":"Sittikul","year":"2018","journal-title":"Biochimie"},{"issue":"2","key":"10.1016\/j.bioorg.2026.109647_bb0395","first-page":"378","article-title":"Protein disulfide isomerase assists export of malaria effectors from the endoplasmic reticulum","volume":"95","author":"Mahajan","year":"2015","journal-title":"Mol. Microbiol."},{"key":"10.1016\/j.bioorg.2026.109647_bb0400","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1073\/pnas.022630099","article-title":"Four plasmepsins are active in the food vacuole of the malaria parasite plasmodium falciparum","volume":"99","author":"Banerjee","year":"2002","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"9","key":"10.1016\/j.bioorg.2026.109647_bb0405","doi-asserted-by":"crossref","first-page":"879","DOI":"10.2174\/138920008786485100","article-title":"In vitro solubility assays in drug discovery","volume":"9","author":"Kerns","year":"2008","journal-title":"Curr. Drug Metab."},{"issue":"2","key":"10.1016\/j.bioorg.2026.109647_bb0410","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/S2055-6640(20)30016-9","article-title":"A review of the safety of favipiravir - a potential treatment in the COVID-19 pandemic?","volume":"6","author":"Pilkington","year":"2020","journal-title":"J. Virus Erad."},{"issue":"7","key":"10.1016\/j.bioorg.2026.109647_bb0415","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1016\/j.ejca.2003.12.004","article-title":"Dihydropyrimidine dehydrogenase and the efficacy and toxicity of 5-fluorouracil","volume":"40","author":"Van","year":"2004","journal-title":"Eur. J. Cancer"},{"issue":"1","key":"10.1016\/j.bioorg.2026.109647_bb0420","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/00498250110085845","article-title":"CYP3A4-mediated hepatic metabolism of the HIV-1 protease inhibitor saquinavir in vitro","volume":"32","author":"Eagling","year":"2002","journal-title":"Xenobiotica"},{"issue":"7281","key":"10.1016\/j.bioorg.2026.109647_bb0425","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1038\/nature08726","article-title":"Plasmepsin V licenses plasmodium proteins for export into the host erythrocyte","volume":"463","author":"Russo","year":"2010","journal-title":"Nature"}],"container-title":["Bioorganic Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206826001835?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206826001835?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T11:59:57Z","timestamp":1777463997000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0045206826001835"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":85,"alternative-id":["S0045206826001835"],"URL":"https:\/\/doi.org\/10.1016\/j.bioorg.2026.109647","relation":{},"ISSN":["0045-2068"],"issn-type":[{"value":"0045-2068","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Repurposing amide-based drugs unveils inhibition mechanisms of plasmodium falciparum Plasmepsin V enzymatic activity for antimalarial therapy","name":"articletitle","label":"Article Title"},{"value":"Bioorganic Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bioorg.2026.109647","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"109647"}}